Population pharmacokinetic analysis of isoniazid, acetylisoniazid, and isonicotinic acid in healthy volunteers

about

Isoniazid metabolism and hepatotoxicity Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI Global Urine Metabolomics in Patients Treated with First-Line Tuberculosis Drugs and Identification of a Novel Metabolite of Ethambutol

P2860

Q28076859-8EAD72CA-5D1E-4097-9504-66F8121D8E0E Q35903844-4A2F5439-7045-4E98-A1CB-3553B4A012ED Q35911355-448A7259-EE26-4E2E-B6B5-1ED074672137

P2860

Population pharmacokinetic analysis of isoniazid, acetylisoniazid, and isonicotinic acid in healthy volunteers

Item

http://www.wikidata.org/entity/Q36158322

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Population pharmacokinetic ana ...... nic acid in healthy volunteers

@ast

Population pharmacokinetic ana ...... nic acid in healthy volunteers

@en

type

Item

label

Population pharmacokinetic ana ...... nic acid in healthy volunteers

@ast

Population pharmacokinetic ana ...... nic acid in healthy volunteers

@en

prefLabel

Population pharmacokinetic ana ...... nic acid in healthy volunteers

@ast

Population pharmacokinetic ana ...... nic acid in healthy volunteers

@en

P1476

Population pharmacokinetic ana ...... nic acid in healthy volunteers

@en

P2093

Gaik-Hong Soon

http://www.w3.org/2001/XMLSchema#string

Kim-Hor Hee

http://www.w3.org/2001/XMLSchema#string

Kok-Yong Seng

http://www.w3.org/2001/XMLSchema#string

Lawrence Soon-U Lee

http://www.w3.org/2001/XMLSchema#string

Nicholas Chew

http://www.w3.org/2001/XMLSchema#string

P2860

A web server for inferring the human N-acetyltransferase-2 (NAT2) enzymatic phenotype from NAT2 genotype

Genetic contribution to variable human CYP3A-mediated metabolism

Prediction of creatinine clearance from serum creatinine

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?

CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.

Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients.

Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide

Pharmacokinetic modeling of plasma and intracellular concentrations of raltegravir in healthy volunteers.

Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats.

P304

6791-6799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01244-15

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

S Khoo

P577

2015-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26282412

http://www.w3.org/2001/XMLSchema#string

P932

4604378

http://www.w3.org/2001/XMLSchema#string

Population pharmacokinetic analysis of isoniazid, acetylisoniazid, and isonicotinic acid in healthy volunteers

about

P2860

P2860

Population pharmacokinetic analysis of isoniazid, acetylisoniazid, and isonicotinic acid in healthy volunteers

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932